Financial Statements
Condensed Consolidated Income Statement
| 1 Jan - 31 Mar (unaudited) | Last 12 months ended 31 March | Year ended 31 December | |||
|---|---|---|---|---|---|
| NOK thousands | Notes | 2026 | 2025 | 2026 | 2025 |
| Revenue from contracts with customers | 3 | 231,677 | 162,505 | 870,114 | 800,943 |
| Other operating income | - | - | 66 | 66 | |
| Total revenue | 231,677 | 162,505 | 870,180 | 801,008 | |
| Raw materials and consumables used | (69,196) | (44,212) | (246,654) | (221,670) | |
| Employee benefit expenses | (82,839) | (51,800) | (273,433) | (242,394) | |
| Depreciation and amortisation | (6,938) | (3,471) | (21,875) | (18,407) | |
| Disposal of property, plant and equipment | - | - | (29) | (29) | |
| Other operating expenses | (36,347) | (28,283) | (155,852) | (147,789) | |
| Total operating expenses | (195,320) | (127,766) | (697,843) | (630,289) | |
| Operating profit/(loss) | 36,357 | 34,739 | 172,337 | 170,719 | |
| Net finance income and finance expenses | (2,502) | (8,102) | 4,339 | (1,261) | |
| Profit before tax | 33,855 | 26,637 | 176,676 | 169,458 | |
| Income tax expense | (8,276) | (5,794) | (42,778) | (40,296) | |
| Profit/(loss) for the period | 25,579 | 20,843 | 133,898 | 129,162 | |
| Items that may be reclassified to profit or loss: | |||||
| Exchange difference on translation of foreign operations | (375) | 1,382 | (2,465) | (709) | |
| Total other comprehensive income | (375) | 1,382 | (2,465) | (709) | |
| Total comprehensive income for the period attributable to the ordinary shareholders of the parent company | 25,204 | 22,225 | 131,433 | 128,453 | |
| Earning per share for profit attributable to the ordinary equity holers of the company: | |||||
| Earnings per share | |||||
| - Basic earnings per share | 0.65 | 0.56 | 3.46 | 3.40 | |
| - Diluted earnings per share | 0.65 | 0.56 | 3.46 | 3.40 | |
| Average number of outstanding shares in thousands | |||||
| - Basic | 39,096 | 37,506 | 38,735 | 37,971 | |
| - Diluted | 39,096 | 37,506 | 38,735 | 37,971 | |
Condensed Consolidated Balance Sheet
| As at 31 March (unaudited) | As at 31 December | ||
|---|---|---|---|
| NOK thousands | Notes | 2026 | 2025 |
| ASSETS | |||
| Non-current assets | |||
| Property, plant and equipment | 30,534 | 30,844 | |
| Intangible assets | 4 | 82,839 | 66,005 |
| Right-of-use assets | 61,298 | 54,142 | |
| Deferred tax assets | 7,864 | 7,102 | |
| Total non-current assets | 182,536 | 158,093 | |
| Current assets | |||
| Inventories | 71,396 | 46,577 | |
| Trade receivables | 149,216 | 108,839 | |
| Other current assets | 53,883 | 45,372 | |
| Financial assets at fair value through profit or loss | 5 | 413,455 | 438,608 |
| Cash and cash equivalents | 6 | 62,157 | 60,490 |
| Total current assets | 750,108 | 699,886 | |
| Total assets | 932,644 | 857,979 | |
| As at 31 March (unaudited) | As at 31 December | ||
|---|---|---|---|
| NOK thousands | Notes | 2026 | 2025 |
| EQUITY AND LIABILITIES | |||
| EQUITY | |||
| Share capital | 1,237 | 1,237 | |
| Share premium | 109,232 | 109,232 | |
| Treasury shares | (19) | (19) | |
| Share-based payment reserve | 2,998 | - | |
| Retained earnings | 503,243 | 477,664 | |
| Other reserves | 1,050 | 1,426 | |
| Total equity | 617,741 | 589,541 | |
| LIABILITIES | |||
| Non-current liabilities | |||
| Lease liabilities | 59,707 | 53,465 | |
| Deferred tax liabilities | 3,731 | 3,504 | |
| Other non current liabilities | 12,878 | 16,243 | |
| Total non current liabilities | 76,317 | 73,212 | |
| Current liabilities | |||
| Trade payables | 56,936 | 34,098 | |
| Other current liabilities | 124,538 | 106,523 | |
| Lease liabilities | 9,684 | 8,642 | |
| Tax liabilities | 45,085 | 43,874 | |
| Provisions | 2,343 | 2,090 | |
| Total current liabilities | 238,586 | 195,226 | |
| Total liabilities | 314,902 | 268,438 | |
| Total equity and liabilities | 932,644 | 857,979 | |
Condensed Consolidated Statement of Equity
| NOK thousands | Notes | Share capital | Share premium | Treasury shares | Share-based payment reserve | Retained earnings | Other reserves | Total equity |
|---|---|---|---|---|---|---|---|---|
| Twelve-month period ended 31 December 2025 | ||||||||
| Balance at 1 January 2025 | 794 | 14,445 | (44) | - | 250,355 | 2,135 | 267,685 | |
| Profit/(loss) for the period | - | - | - | - | 129,162 | - | 129,162 | |
| Other comprehensive income/(loss) | - | - | - | - | - | (709) | (709) | |
| Total comprehensive profit/(loss) | - | - | - | - | 129,162 | (709) | 128,453 | |
| Transfer between reserves | 397 | (397) | (21) | - | 21 | - | ||
| Issue of new share | 45 | 95,184 | - | - | - | - | 95,229 | |
| Sale of own shares | - | - | 46 | - | 98,125 | - | 98,171 | |
| Balance at 31 March 2025 | 1,236 | 109,232 | (19) | - | 477,664 | 1,426 | 589,538 | |
| Three-month period ended 31 March 2025 (unaudited) | ||||||||
| Balance at 1 January 2025 | 794 | 14,445 | (44) | - | 250,355 | 2,135 | 267,685 | |
| Profit/(loss) for the period | - | - | - | - | 20,843 | - | 129,162 | |
| Other comprehensive income/(loss) | - | - | - | - | - | 1,382 | (709) | |
| Total comprehensive profit/(loss) | 794 | 14,445 | (44) | - | 271,198 | 3,517 | 396,138 | |
| Transfer between reserves | - | - | - | - | - | - | - | |
| Issue of new share | - | - | - | - | - | - | - | |
| Sale of own shares | - | - | - | - | - | - | - | |
| Balance at 31 March 2025 | 794 | 14,445 | (44) | - | 271,198 | 3,517 | 396,138 | |
| Three-month period ended 31 March 2026 (unaudited) | ||||||||
| Balance at 1 January 2026 | 1,236 | 109,232 | (19) | - | 477,664 | 1,426 | 589,538 | |
| Profit/(loss) for the period | - | - | - | - | 25,579 | - | 25,579 | |
| Other comprehensive income/(loss) | - | - | - | - | - | (375) | (375) | |
| Total comprehensive profit/(loss) | 1,236 | 109,232 | (19) | - | 503,243 | 1,051 | 614,743 | |
| Transfer between reserves | - | - | - | - | - | - | - | |
| Share-based payment charge | - | - | - | 2,998 | - | - | 2,998 | |
| Issue of new share | - | - | - | - | - | - | - | |
| Sale of own shares | - | - | - | - | - | - | - | |
| Balance at 31 March 2026 | 1,236 | 109,232 | (19) | 2,998 | 503,243 | 1,051 | 617,741 | |
Condensed Consolidated Cash Flow Statement
| 1 Jan - 31 Mar (unaudited) | Last 12 months ended 31 March | Year ended 31 December | |||
|---|---|---|---|---|---|
| NOK thousands | Notes | 2026 | 2025 | 2026 | 2025 |
| CASHFLOW FROM OPERATING ACTIVITIES | |||||
| Profit/(loss) before income tax | 33,855 | 26,637 | 176,676 | 169,458 | |
| Adjustments for | |||||
| Depreciation and amortisation | 6,938 | 3,471 | 21,875 | 18,407 | |
| Disposal of property, plant and equipment | - | - | 29 | 29 | |
| Net interest income & finance expenses | 940 | 577 | 1,250 | 887 | |
| Net fair value (gains)/losses on money market funds | 5 | (4,846) | (1,473) | (13,370) | (9,998) |
| Share-based payment charge | 2,998 | - | 2,998 | - | |
| Non-cash items | 2,510 | (476) | 2,760 | (226) | |
| Decrease/(increase) in inventories | (27,241) | 532 | (30,645) | (2,872) | |
| Decrease/(increase) in trade receivables | (39,707) | (5,078) | (60,766) | (26,137) | |
| Decrease/(increase) in other current assets | (8,468) | (3,157) | (13,235) | (7,924) | |
| Increase/(decrease) in trade payables | 22,381 | 11,704 | 31,394 | 20,717 | |
| Increase/(decrease) in other current liabilities | 13,067 | (4,814) | 36,929 | 19,049 | |
| Income taxes paid | (7,606) | (170) | (25,581) | (18,145) | |
| Total cash flow from operating activities | (5,180) | 27,753 | 130,314 | 163,247 | |
| CASHFLOW FROM INVESTMENT ACTIVITIES | - | ||||
| Purchase of property, plant and equipment | (2,032) | (3,090) | (22,802) | (23,860) | |
| Purchase of on intangible assets | 4 | (17,753) | (16,278) | (67,712) | (66,237) |
| Purchase of money market funds | 5 | - | (20,000) | (315,000) | (335,000) |
| Proceeds from sale of money market funds | 5 | 30,000 | - | 70,000 | 40,000 |
| Interests received | 53 | 292 | 2,902 | 3,141 | |
| Total cash flow from investment activities | 10,268 | (39,076) | (332,612) | (381,956) | |
| CASHFLOW FROM FINANCING ACTIVITIES | - | ||||
| Repayment of lease liabilities | (2,146) | (641) | (6,452) | (4,948) | |
| Interests paid | (993) | (869) | (4,152) | (4,029) | |
| Proceeds from issue of shares | - | - | 95,229 | 95,229 | |
| Proceeds from sale/(purchase) of treasury shares | - | - | 98,171 | 98,171 | |
| Total cash flow from financing activities | (3,139) | (1,511) | 182,795 | 184,424 | |
| Net change in cash and cash equivalents | 1,950 | (12,833) | (19,503) | (34,285) | |
| - | |||||
| Cash and cash equivalents at the beginning of the period | 60,490 | 96,825 | 83,006 | 96,825 | |
| Net foreign exchange differences | (283) | (986) | (1,346) | (2,049) | |
| Cash and cash equivalents at the end of the period | 62,157 | 83,006 | 62,157 | 60,490 | |

